当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析

国药一致

(000028)

  

流通市值:121.33亿  总市值:141.26亿
流通股本:4.78亿   总股本:5.57亿

国药一致(000028)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润3.48亿元,每股收益0.59元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益2110194.31万元,未分配利润1290354.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产5002304.22万元,负债2892109.91万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入18,293,519,382.4974,378,494,389.5756,466,354,478.3737,785,980,620.95
营业总成本17,881,473,183.9873,017,475,226.7755,384,596,098.9737,024,016,079.6
营业利润439,138,215.7573,478,281.111,344,444,922.23948,860,093.44
利润总额438,326,864.61575,469,437.321,356,463,270.05957,968,900.2
净利润347,677,306.8237,003,526.491,095,669,310.29770,054,628.11
其他综合收益--15,541,136.14-13,914.59-13,914.59
综合收益总额347,677,306.8221,462,390.351,095,655,395.7770,040,713.52
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计40,139,860,703.337,576,395,698.7740,678,316,958.9639,892,558,310.53
非流动资产合计9,883,181,465.799,979,464,716.4511,302,538,613.3511,512,683,077.3
资产总计50,023,042,169.0947,555,860,415.2251,980,855,572.3151,405,241,387.83
流动负债合计27,037,737,859.0724,802,407,197.7928,092,983,684.0627,673,005,280.59
非流动负债合计1,883,361,206.631,998,053,899.612,233,506,658.272,383,293,314.9
负债合计28,921,099,065.726,800,461,097.430,326,490,342.3330,056,298,595.49
归属于母公司股东权益合计17,997,526,867.7817,669,528,375.6518,101,879,082.9917,779,820,945.4
股东权益合计21,101,943,103.3920,755,399,317.8221,654,365,229.9821,348,942,792.34
负债和股东权益合计50,023,042,169.0947,555,860,415.2251,980,855,572.3151,405,241,387.83
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计16,224,803,696.9380,408,700,561.6156,625,996,162.0237,492,026,106.11
经营活动现金流出小计18,042,073,694.7777,137,232,264.5855,344,904,053.9336,562,648,597.33
经营活动产生的现金流量净额-1,817,269,997.843,271,468,297.031,281,092,108.09929,377,508.78
投资活动现金流入小计4,362,484.59217,442,245.19216,988,662.2646,593,517.92
投资活动现金流出小计64,305,655.73368,127,854.62288,221,019.36216,000,904.19
投资活动产生的现金流量净额-59,943,171.14-150,685,609.43-71,232,357.1-169,407,386.27
筹资活动现金流入小计661,184,385.131,824,239,928.711,410,753,157.681,264,981,342.78
筹资活动现金流出小计569,123,338.513,655,476,076.733,396,976,558.982,311,769,640.15
筹资活动产生的现金流量净额92,061,046.62-1,831,236,148.02-1,986,223,401.3-1,046,788,297.37
汇率变动对现金及现金等价物的影响873.42-1,196,465.06-1,200,190.66-1,224,255.9
现金及现金等价物净增加额-1,785,151,248.941,288,350,074.52-777,563,840.97-288,042,430.76
期末现金及现金等价物余额5,338,493,281.937,123,644,530.875,057,730,615.385,547,252,025.59
最新报告期:2025-04-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中金公司张琎,朱言音1.621.80--2025-04-25
中信证券宋硕,陈竹,沈睦钧2.462.592.882025-04-25
中金公司张琎,朱言音1.621.80--2025-04-10
华泰证券代雯,孔垂岩,王殷杰2.542.582.622025-04-08
西南证券杜向阳,汪翌雯2.372.68--2025-03-20
TOP↑